Skip to main content
AlteraDiagnostics
The Science

Dual biomarker technology for precise differentiation

FebriDx measures two host-response proteins — CRP and MxA — simultaneously to differentiate bacterial from non-bacterial acute respiratory infections with clinical-grade accuracy.

Host-Response Signature

Twoproteins.Onedefinitiveanswer.

Pathogens leave the immune system a measurable fingerprint. FebriDx reads two of them at once — a dual signature no single-marker assay can match.

Biomarker 01Bacterial Signal

CRP

C-Reactive Protein

An acute-phase protein produced by the liver in response to inflammatory cytokines like IL-6. Rises in both bacterial and viral infection — sensitive, but not specific enough on its own.

Response curveTime from infection →
Threshold
20mg/L
Onset
4–6hrs
Peak
36hrs
Biomarker 02Viral Signal

MxA

Myxovirus Resistance Protein A

An innate biomarker induced exclusively by interferon during viral infection. Not elevated by bacteria — giving FebriDx the specificity a CRP-only test cannot achieve.

Response curveTime from infection →
Threshold
40ng/mL
Onset
1–2hrs
Half-life
2.3days

Neitheraloneisenough.Together,theytransformdiagnosis.

Neither MxA nor CRP alone is sensitive or specific enough to differentiate bacterial infection from non-bacterial etiology. However, when both host response biomarkers are measured together in the FebriDx test, bacterial infection can be reliably differentiated from non-bacterial etiologies.

CRP — Bacterial response85%
MxA — Viral specificity92%
Combined — FebriDx sensitivity93.2%
Clinician performing a FebriDx test in a clinical setting
Clinical Performance

Trialdata,plainlystated.

A prospective, multi-center, double-blinded U.S. trial conducted between October 2019 and April 2021 and published in JAMA Network Open.

520
Participants
20
Clinical sites
0
Adverse events
Headline Outcome
98.7%
Negative Predictive Value

When FebriDx reads negative for bacterial infection, it is right 98.7% of the time — giving clinicians the confidence to safely withhold antibiotics.

374 of 37995% CI 96.9 – 99.4%
Sensitivity
Positive Percent Agreement
68 / 73 · 95% CI 84.9–97.0%
93.2%
Specificity
Negative Percent Agreement
374 / 423 · 95% CI 85.0–91.1%
88.4%
PPV
Positive Predictive Value
68 / 117 · 95% CI 49.1–66.7%
58.1%
Peer-Reviewed Publication

Diagnostic Accuracy of a Bacterial and Viral Biomarker Point-of-Care Test in the Outpatient Setting

Shapiro NI, Filbin MR, Hou PC, et al. JAMA Network Open. 2022;5(10):e2234588.

Read the full study

Theantimicrobialresistancecrisis

Acute respiratory infections are the most common reason for physician office visits and antibiotic prescriptions worldwide. The significant overlap in symptoms makes it challenging to differentiate bacterial from non-bacterial infections.

The vast majority of ARIs are caused by non-bacterial etiology, yet 30-80% receive antibiotics. This overprescription is a leading contributor to the global antimicrobial resistance crisis, which currently causes over 1.27 million deaths annually.

FebriDx supports antimicrobial stewardship by giving clinicians an objective, rapid tool to determine whether antibiotics are truly needed — reducing unnecessary prescriptions while ensuring bacterial infections are not overlooked.

Prescription antibiotic pills spilling from a bottle — the antimicrobial resistance crisis